The potential of ACE2/Ang1‐7 to rebalance the severely disrupted renin–angiotensin axis suggests a potential benefit in more severely ill patients with acute respiratory distress syndrome, with or without COVID‐19, where low ACE2 and Ang(1‐7) have been linked to poor prognosis. Here, ACE2 is linked to acute respiratory distress syndrome.